Patents by Inventor Yeon Hee Ban

Yeon Hee Ban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FK506 derivative maintaining nerve regeneration activity without immunosuppressive activity, and use thereof
    Patent number: 10576060
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Grant
    Filed: January 8, 2019
    Date of Patent: March 3, 2020
    Assignee: INTRON BIOTECHNOLOGY CO., LTD
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb
  • FK506 DERIVATIVE MAINTAINING NERVE REGENERATION ACTIVITY WITHOUT IMMUNOSUPPRESSIVE ACTIVITY, AND USE THEREOF
    Publication number: 20190134001
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Application
    Filed: January 8, 2019
    Publication date: May 9, 2019
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb
  • FK506 derivative maintaining nerve regeneration activity without immunosuppressive activity, and use thereof
    Patent number: 10226446
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: March 12, 2019
    Assignee: INTRON BIOTECHNOLOGY CO., LTD
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb
  • Pharmaceutical composition containing FK506 derivative for treating fungal infection caused by genus and genus and use thereof
    Patent number: 9855253
    Abstract: The present invention relates to a pharmaceutical composition containing FK506 derivative for treating a fungal infection caused by the genus Cryptococcus or the genus Candida, and a use thereof. In addition, the present invention relates to a therapeutic agent for fungal infection caused by the genus Cryptococcus or the genus Candida, the therapeutic agent containing FK506 derivative. The pharmaceutical composition of the present invention is harmless to the human body, and can make a great contribution to providing antifungal drugs with an excellent antifungal effect.
    Type: Grant
    Filed: June 29, 2015
    Date of Patent: January 2, 2018
    Assignee: INTRON BIOTECHNOLOGY CO., LTD.
    Inventors: Yong Sun Bahn, Hyo Jeong Kwon, Yeo Joon Yoon, Yeon Hee Ban
  • FK506 DERIVATIVE MAINTAINING NERVE REGENERATION ACTIVITY WITHOUT IMMUNOSUPPRESSIVE ACTIVITY, AND USE THEREOF
    Publication number: 20170216254
    Abstract: The present invention relates to an FK506 derivative which has reduced immunosuppressive activity but maintains nerve regeneration activity, a preparing method thereof, and a pharmaceutical composition comprising the same for preventing or treating nervous system diseases. A composition comprising 9-deoxo-prolyl-FK506, 31-O-demethyl-FK506, or 9-deoxo-31-O-demethyl-FK506 can promote nerve regeneration and has reduced immunosuppressive activity, thereby reducing side effects in the treatment of nervous system diseases.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 3, 2017
    Inventors: Yeo Joon Yoon, Ho Jeong Kwon, Yeon Hee Ban, Shinde Pramodb
  • PHARMACEUTICAL COMPOSITION CONTAINING FK506 DERIVATIVE FOR TREATING FUNGAL INFECTION CAUSED BY GENUS CRYPTOCOCCUS AND GENUS CANDIDA AND USE THEREOF
    Publication number: 20170135993
    Abstract: The present invention relates to a pharmaceutical composition containing FK506 derivative for treating a fungal infection caused by the genus Cryptococcus or the genus Candida, and a use thereof. In addition, the present invention relates to a therapeutic agent for fungal infection caused by the genus Cryptococcus or the genus Candida, the therapeutic agent containing FK506 derivative. The pharmaceutical composition of the present invention, is harmless to the human body, and can make a great contribution to providing antifungal drugs with an excellent antifungal effect.
    Type: Application
    Filed: June 29, 2015
    Publication date: May 18, 2017
    Inventors: Yong Sun Bahn, Hyo Jeong Kwon, Yeo Joon Yoon, Yeon Hee Ban